the International Task Force on Canine Atopic Dermatitis

*Department of Clinical Sciences and Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, USA Clinic for Small Animal Internal Medicine, Dermatology Department, Vetsuisse Faculty, University of ZÏrich, ZÏrich, Switzerland Dermatology Referral Services, Glasgow, Scotland Medizinische Kleintierklinik, Ludwig-Maximilians University, Munich, Germany **The University of Liverpool School of Veterinary Science, Small Animal Teaching Hospital, Leahurst Campus, Neston, UK Clinique Advetia, Paris, France Correspondence: Thierry Olivry, DrVet, PhD, Department of Clinical Science, North Carolina State University, College of Veterinary Medicine, Research Building, 4700 Hillsborough Street, Raleigh, NC 27606, USA. Email: Thierry_Olivry@ncsu.edu 2009 年國際犬異位性皮膚炎調查委員會由以下人員組成, 依英文 字母排序 Emmanuel Bensignor (法), Didier Carlotti (法), Douglas J DeBoer (美), Claude Favrot (瑞士), Craig Griffin (美), Richard Halliwell (主席; 英), Bruce Hammerberg (美), Peter Hill (澳洲), Toshiroh Iwasaki (日本), Hilary Jackson (英), Sadatoshi Maeda (日 本), Kenichi Masuda (日本), Rosanna Marsella (美), Ralf Mueller (德), Tim Nuttall (英), Thierry Olivry (美), Pascal Pr elaud (法), Candace Sousa (美) and Ton Willemse (荷蘭). Conflict of Interest 在本文中所提及的藥品或產品,作者群中的作者們提出報告在過 去十年中有為以下公司當諮詢顧問 或/和 接受私人贊助的內容如 下: Thierry Olivry: Novartis Animal Health Global (Basel, Switzerland) and Virbac (Carros, France). Douglas DeBoer: Heska Corporation (Fort Collins, Colorado USA) and Greer Laboratories (Lenoir, North Carolina USA). Claude Favrot: Novartis Animal Health Global (Basel, Switzerland) Hilary Jackson: Nestl e Purina Petcare (St. Louis, Missouri, USA) and Novartis Animal Health Global (Basel, Switzerland) Ralf Mueller: Bayer Animal Health (Leverkusen, Germany), Boehringer Ingelheim (Copenhagen, Denmark), TEVA Animal Health-DVM Pharmaceuticals (St Joseph, Missouri, USA), Procter & Gamble Pet Care (Cincinnati, Ohio, USA), Laboratoire de Dermo-Cosm etique Animale (Castres, France), Novartis Animal Health (Greensborough, North Carolina, USA), Pfizer Animal Health (Karlsruhe, Germany) and Virbac (Carros, France). Tim Nuttall: Virbac (Carros, France), Novartis Animal Health (Basel, Switzerland), Pfizer Animal Health (Sandwich, UK), Intervet-Schering Plough (Milton Keynes, UK), Phytopharm plc (Godmanchester, UK) and Royal Canin (Aimargues, France), Pascal Pr elaud: Novartis Animal Health France (Rueil Malmaison, France), Pfizer Animal Health (Sandwich, UK), Vetoquinol (Paris, France) and Royal Canin (Aimargues, France) 資金來源 未報告 Citing this article This article should be cited as: Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, Pr elaud P for the International Task Force on Canine Atopic Dermatitis. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 2010: 21: 233–248 引用此文獻報告時,請依照下列格式: Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, Pr elaud P for the International Task Force on Canine Atopic Dermatitis. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 2010: 21:233–248 Translation This article was translated in Traditional Chinese by Charles Chen and Tai-An Chen 此文章的繁體中文版本由陳朝澧及陳臺安翻譯